Prognostic Factors in Critically Ill Patients Suffering from Secondary Peritonitis: A Retrospective, Observational, Survival Time Analysis
- 213 Downloads
Acute mortality of unselected critically ill patients has improved during the last 15 years. Whether these benefits also affect survival of critically ill patients with secondary peritonitis is unclear as is the relevance of specific prognostic factors, such as source control.
We performed a retrospective analysis of data collected prospectively from March 1993 to February 2005. A cohort of 319 consecutive postoperative patients with secondary peritonitis requiring intensive care was evaluated. End points for outcome analysis were derived from daily changes of hazard rate.
Four-month survival rate after intensive care unit (ICU) admission was 31.7%. For patients who have survived for more than 4 months, the 1-year survival was 82.7%. After adjustment for relevant covariates, a high disease severity at ICU admission and during ICU stay, specific comorbidities (extended malignancies, liver cirrhosis) and sources of infection (distal esophagus, stomach), and an inadequate initial antibiotic therapy were associated with worse 4-month prognosis. Inability to obtain source control was the most important determinant of mortality, and treatment after 2002 was combined with improved prognosis.
Four-month prognosis of critically ill, surgical patients with secondary peritonitis is poor and mostly determined by the ability to obtain source control. Outcome has improved since 2002, and after successful surgical and intensive care therapy long-term survival seems to be good.
KeywordsIntensive Care Unit Peritonitis Intensive Care Unit Admission Intensive Care Unit Stay Empiric Antibiotic Therapy
The authors thank D. Inthorn and H. Schneeberger for initiation and maintenance of the database.
- 13.Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, Artigas A, Fumagalli R, Macias W, Wright T, Wong K, Sundin DP, Turlo MA, Janes J (2005) Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med 33:2266–2277PubMedCrossRefGoogle Scholar
- 19.Fertmann J, Wolf H, Küchenhoff H, Hofner B, Jauch KW, Hartl WH (2008) Prognostic factors in critically ill, surgical patients requiring continuous renal replacement therapy. J Nephrol (in press)Google Scholar
- 24.Hosmer DW, Lemeshow S (1999) Applied survival analysis. Wiley, New York, p 158Google Scholar
- 25.Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer-Verlag, Berlin Heidelberg, p 128Google Scholar
- 26.Klein JP, Moeschberger ML (2003) Survival analysis. Techniques for censored and truncated data. Springer, New York, p 295Google Scholar
- 27.Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York, p 84Google Scholar
- 31.Van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, de Graaf PW, Lamme B, Gerhards MF, Steller EP, van Till JW, de Borgie CJ, Gouma DJ, Reitsma JB, Boermeester MA, Dutch Peritonitis Study Group (2007) Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis: a randomized trial. JAMA 298:865–872PubMedCrossRefGoogle Scholar
- 38.Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W (2004) Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 23:682–687PubMedCrossRefGoogle Scholar
- 43.Dellinger EP (1995) Intra-abdominal infections: treatment considerations. Infect Dis Clin Pract 4(Suppl 3):S163–S169Google Scholar